InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,346.99
(
-0.11%
)
US TECH 100
18,488.00
(
-0.25%
)
Dow Jones
38,798.99
(
-0.22%
)
Brent Oil
79.40
(
0.00%
)
Bitcoin
69,263.99
(
-0.10%
)
Post# of 252107
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Double_Bagel

Send PM Follow Ignore
Followers 14
Posts 898
Boards Moderated 0
Alias Born 03/07/2011

Double_Bagel

Re: None

Monday, 07/07/2014 7:56:11 AM

Monday, July 07, 2014 7:56:11 AM

Post# of 252107
ENTA downgraded; $50 price target removed

http://www.theflyonthewall.com/permalinks/entry.php/ENTAid2033809/ENTA-Enanta-downgraded-to-Market-Perform-from-Outperform-at-JMP-Securities

Enanta downgraded to Market Perform from Outperform at JMP Securities

JMP Securities downgraded Entana (ENTA) given the unlikelihood of an acquisition by AbbVie (ABBV), now that its pursing Shire (SHPG), and increased competition in the HCV space.

http://www.streetinsider.com/Downgrades/JMP+Securities+Downgrades+Enanta+Pharmaceuticals+%28ENTA%29+to+Market+Perform/9640459.html

JMP Securities downgraded Enanta Pharmaceuticals (NASDAQ: ENTA) from Market Outperform to Market Perform and removed its price target (prior $50).
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up